11
Participants
Start Date
October 23, 2019
Primary Completion Date
February 25, 2020
Study Completion Date
October 31, 2020
Gene Therapy product:vMCO-I
The vMCO-I is an adeno-associated virus serotype 2-based vector carried multi-characteristic opsin (MCO) gene expression cassette
JPM Rotary Club of Cuttack Eye Hospital and Research Institute, Cuttack
Lead Sponsor
Nanoscope Therapeutics Inc.
INDUSTRY